Grant Pickering - 26 Jun 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: PCVX
Reported as of: 26 Jun 2026
Net transaction value: -$1,338,270
SEC form: 4
Accepted by SEC: 26 Jun 2026, 18:49:13 UTC
Prior SEC filing: 24 Jun 2026
Source filing: View source filing
Reporting owner signature: Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact

Key filing fact

Grant Pickering filed Form 4 for Vaxcyte, Inc. (PCVX) on 26 Jun 2026.

Key facts

This page summarizes Grant Pickering's Form 4 filing for Vaxcyte, Inc. (PCVX).
9 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Jun 2026, 18:49.

Change

Previous filing in this sequence was filed on 24 Jun 2026.
Current net transaction value: -$1,338,270.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258693 Primary reporting owner

PICKERING GRANT

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS
Signature: Grant Pickering, by /s/ Peter N. Efremenko, Attorney-In-Fact
Signature date: 26 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Sale

Transaction value: $362,720
Shares: -6,683
Change %: -1.4%
Price: $54.28
Shares after: 468,020
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F1, F2

PCVX transaction

Common Stock

Sale

Transaction value: $504,956
Shares: -9,137
Change %: -2%
Price: $55.26
Shares after: 458,883
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F1, F3

PCVX transaction

Common Stock

Sale

Transaction value: $360,128
Shares: -6,417
Change %: -1.4%
Price: $56.12
Shares after: 452,466
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F1, F4

PCVX transaction

Common Stock

Sale

Transaction value: $16,956
Shares: -312
Change %: -0.23%
Price: $54.34
Shares after: 134,903
Date: 26 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F5, F6

PCVX transaction

Common Stock

Sale

Transaction value: $19,660
Shares: -356
Change %: -0.26%
Price: $55.23
Shares after: 134,547
Date: 26 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F6, F7

PCVX transaction

Common Stock

Sale

Transaction value: $18,590
Shares: -332
Change %: -0.25%
Price: $55.99
Shares after: 134,215
Date: 26 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F6, F8

PCVX transaction

Common Stock

Sale

Transaction value: $11,224
Shares: -207
Change %: -0.15%
Price: $54.22
Shares after: 135,008
Date: 26 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F9, F10

PCVX transaction

Common Stock

Sale

Transaction value: $33,289
Shares: -602
Change %: -0.45%
Price: $55.30
Shares after: 134,406
Date: 26 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F10, F11

PCVX transaction

Common Stock

Sale

Transaction value: $10,747
Shares: -191
Change %: -0.14%
Price: $56.27
Shares after: 134,215
Date: 26 Jun 2026
Ownership: By Children's Trust
Footnotes: F1, F10, F12

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 12 footnotes

Footnote F1

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026.

Footnote F2

The price reported is a weighted-average price. The shares were sold at prices ranging from $53.755 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

The price reported is a weighted-average price. The shares were sold at prices ranging from $54.755 to $55.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F4

The price reported is a weighted-average price. The shares were sold at prices ranging from $55.815 to $56.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F5

The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F6

Shares are held directly by a trust for the benefit of the Reporting Person's son.

Footnote F7

The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.51. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F8

The price reported is a weighted-average price. The shares were sold at prices ranging from $55.88 to $56.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F9

The price reported is a weighted-average price. The shares were sold at prices ranging from $53.77 to $54.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F10

Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

Footnote F11

The price reported is a weighted-average price. The shares were sold at prices ranging from $54.80 to $55.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F12

The price reported is a weighted-average price. The shares were sold at prices ranging from $56.00 to $56.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.